Joerg Herrmann

17.1k citations

202 papers · 8.5k indexed · 2 hit papers · h-index 50

Impact in

Cardiology and Cardiovascular Medicine top 0.2%
- Chemotherapy-induced cardiotoxicity and mitigation
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
Radiology, Nuclear Medicine and Imaging top 0.5%
- Cardiac Imaging and Diagnostics

Papers in

Cardiology and Cardiovascular Medicine 135
- Chemotherapy-induced cardiotoxicity and mitigation 84
- Acute Myocardial Infarction Research 25
- Cardiac tumors and thrombi 17
- Heart Failure Treatment and Management 10
- Cardiovascular Function and Risk Factors 10
Radiology, Nuclear Medicine and Imaging 77
- Cardiac Imaging and Diagnostics 70

Co-authors: Amir Lerman Rhian M. Touyz Abhiram Prasad Lilach O. Lerman Sandra M. Herrmann Feilong Wang David R. Holmes Hector R. Villarraga
Journals: European Heart Journal (15 papers)Journal of the American College of Cardiology (14 papers)Journal of Clinical Oncology (7 papers)Catheterization and Cardiovascular Interventions (7 papers)Circulation (6 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Joerg Herrmann

189 papers receiving 8.3k citations

Hit Papers

align trajectories log scale

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia 2020 · 436 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Nature Reviews Cardiology
2018 Therapeutic Advances in Medical Oncology

Peers

Countries citing papers authored by Joerg Herrmann

Since Specialization

Citations

This map shows the geographic impact of Joerg Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Herrmann more than expected).

Fields of papers citing papers by Joerg Herrmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Herrmann. The network helps show where Joerg Herrmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Joerg Herrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joerg Herrmann Line = papers co-authored together Joerg Herrmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Radionuclide imaging in cardio-oncology: A clinical decision-making tool Progress in Cardiovascular Diseases ·Teodora Donisan, Daniel Sykora, Dinu Valentin Balanescu, Ian C Chang, Grace Lin, Joerg Herrmann, Martin Rodriguez‐Porcel	2025	0
2	UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long‐Established Target Mitochondrial Pyruvate Carrier Advanced Science ·Linyu Ran, Miao Chen, Jihui Ye, Song Zhang, Zhibing Luo, Tengfei Bai, Chenchen Qian, Quan Zhou, Mengtian Shan, Yong Chu, Joerg Herrmann, Qiang Li, Feilong Wang	2024	8
3	Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignancies Cardio-Oncology ·Andres Daryanani, Muhannad Abbasi, M Roa, Eduardo Tellez‐Garcia, Juan Manuel Garzón-Dangond, Yi Lin, Jonas Paludo, Joerg Herrmann, Stephen M. Ansell, Allison Rosenthal, Hector R. Villarraga	2024	2
4	Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity Cardiovascular Research ·Thais Peclat, Guillermo Agorrody, Laura Colman, Sonu Kashyap, Julianna D. Zeidler, Claudia C.S. Chini, Gina M. Warner, Katie L. Thompson, Pranjali Dalvi, Felipe Beckedorff, Sanam Ebtehaj, Joerg Herrmann, Wim van Schooten, Eduardo N. Chini	2024	5
5	Cardiac Masses Discovered by Echocardiogram; What to Do Next? Structural Heart ·Reto Kurmann, Edward El‐Am, Ali Ahmad, Muhannad Abbasi, Piotr Mazur, Elias Akiki, Vidhu Anand, Joerg Herrmann, Ana I. Casanegra, Phillip M. Young, Juan A. Crestanello, Melanie C. Bois, Joseph J. Maleszewski, Kyle W. Klarich	2023	7
6	Changes in amount and intensity of physical activity over time in breast cancer survivors JNCI Cancer Spectrum ·Paulina S. Marell, Robert A. Vierkant, Janet E. Olson, Joerg Herrmann, Nicole L. Larson, Nathan K. LeBrasseur, Stacy D D’Andre, Diane K. Ehlers, Daniela Stan, Andrea Cheville, Toure Barksdale, Charles L. Loprinzi, Fergus J. Couch, Kathryn J. Ruddy	2023	7
7	The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology European Heart Journal ·Joerg Herrmann, Teresa López‐Fernández, Alexander R. Lyon	2023	1
8	Mitochondrial pyruvate carrier-mediated metabolism is dispensable for the classical activation of macrophages Nature Metabolism ·Linyu Ran, Song Zhang, Guosheng Wang, Pei Zhao, Jiaxing Sun, Jiaqi Zhou, Haiyun Gan, Ryoung‐Hoon Jeon, Qiang Li, Joerg Herrmann, Feilong Wang	2023	23
9	Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade Journal of the American Heart Association ·J. Jacobs, Wouter L’Hoyes, Lieselotte Lauwens, Yu‐Ling Yu, Marius Brusselmans, Caroline Weltens, Jens‐Uwe Voigt, Hans Wildiers, Patrick Neven, Joerg Herrmann, Lutgarde Thijs, Jan A. Staessen, Stefan Janssens, Lucas Van Aelst	2023	13
10	Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer JACC CardioOncology ·Samuel A. Shabtaie, Nicholas Y. Tan, Robert C. Ward, Bradley R. Lewis, Eric H. Yang, David R. Holmes, Joerg Herrmann	2023	16
11	Factors Associated With Physical Activity Levels in Patients With Breast Cancer The Oncologist ·Paulina S. Marell, Robert A. Vierkant, Janet E. Olson, Joerg Herrmann, Nicole Larson, Nathan K. LeBrasseur, Stacy D D’Andre, Andrea Cheville, Toure Barksdale, Charles L. Loprinzi, Fergus J. Couch, Kathryn J. Ruddy	2022	4
12	Advancing Cardio-Oncology in Asia Korean Circulation Journal ·Choon Ta Ng, Li Ling Tan, Il Suk Sohn, Hilda Mariana Gonzalez Bonilla, Toru Oka, Teerapat Yinchoncharoen, Ting‐Wei Chang, Jun Hua Chong, Maria Katrina Cruz Tan, Rochelle Regina Cruz, Astri Astuti, Vivek Agarwala, Do Van Chien, Jong‐Chan Youn, Jieli Tong, Joerg Herrmann	2022	4
13	Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era American Journal of Hematology ·Nicholas Boddicker, Melissa C. Larson, Alessia Castellino, Joerg Herrmann, David J. Inwards, Gita Thanarajasingam, Matthew J. Maurer, Cristine Allmer, Thomas E. Witzig, Grzegorz S. Nowakowski, Thomas M. Habermann, Hector R. Villarraga, Susan L. Slager, James R. Cerhan, Carrie A. Thompson	2021	10
14	The year in cardiovascular medicine 2021: cardio-oncology European Heart Journal ·Joerg Herrmann, Teresa López‐Fernández, Alexander R. Lyon	2021	8
15	atg7 -Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity Circulation Research ·Yong Wang, Xiaoguang Lu, Xiaoping Wang, Qi Qiu, Ping Zhu, Lin Ma, Xiao Ma, Joerg Herrmann, Xueying Lin, Wei Wang, Xiaolei Xu	2021	64
16	Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building Current Oncology Reports ·Diego Sadler, Anita Arnold, Joerg Herrmann, Andrés J. Daniele, Carolina Maria Pinto Domingues Carv Silva, Arjun K. Ghosh, Sebastian Szmit, Roohi Ismail Khan, Luis E. Raez, Anne Blaes, Sherry‐Ann Brown	2021	11
17	Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single‐center analysis Cancer ·Itunu Owoyemi, Lisa E. Vaughan, Collin M. Costello, Charat Thongprayoon, Svetomir N. Markovic, Joerg Herrmann, Clark C. Otley, Timuçin Taner, Aaron R. Mangold, Nelson Leung, Sandra M. Herrmann, Aleksandra Kukla	2020	27
18	A Comparison of Proton and X-ray Therapy for Coronary Artery Sparing Using ECG-gated CT with Coronary Angiography for Mediastinal Lymphoma International Journal of Radiation OncologyBiologyPhysics ·Kekoa Taparra, Scott C. Lester, Ashley Hunzeker, R.K. Funk, M.J. Blanchard, Phillip M. Young, Joerg Herrmann, A Tasson, Shuang Leng, James A. Martenson, Thomas J. Whitaker, Eric E. Williamson, Nadia N. Laack	2018	1
19	Body Mass Index and Acute and Long-Term Outcomes After Acute Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial) The American Journal of Cardiology ·Joerg Herrmann, Bernard J. Gersh, Judith Z. Goldfinger, Bernhard Witzenbichler, Giulio Guagliumi, Dariusz Dudek, Ran Kornowski, Sorin J. Brener, Helen Parise, Martin Fahy, Thomas McAndrew, Gregg W. Stone, Roxana Mehran	2014	33
20	Coronary microvascular dysfunction in the clinical setting: from mystery to reality European Heart Journal ·Joerg Herrmann, J. C. Kaski, Amir Lerman	2012	157

About Joerg Herrmann

Joerg Herrmann is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Internal Medicine and Surgery, having authored 202 papers that have together received 8.5k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (84 papers), Cardiac Imaging and Diagnostics (70 papers), Cancer Treatment and Pharmacology (29 papers), Coronary Interventions and Diagnostics (28 papers), Acute Myocardial Infarction Research (25 papers), Cardiac tumors and thrombi (17 papers), Heart Failure Treatment and Management (10 papers) and Cardiovascular Function and Risk Factors (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (4.6k citations), Radiology, Nuclear Medicine and Imaging (2.0k citations), Oncology (1.9k citations), Internal Medicine (217 citations) and Immunology (1.1k citations). Joerg Herrmann has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Amir Lerman, Rhian M. Touyz, Abhiram Prasad, Lilach O. Lerman, Sandra M. Herrmann, Feilong Wang, David R. Holmes, Hector R. Villarraga, Nicole P. Sandhu and Cezar Iliescu. Their work appears in journals such as European Heart Journal, Journal of the American College of Cardiology, Journal of Clinical Oncology, Catheterization and Cardiovascular Interventions and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact